Breast cancers with a HER2/CEP17 ratio of 2.0 or greater and an average HER2 copy number of less than 4.0 per cell: frequency, immunohistochemical correlation, and clinicopathological features - ScienceDirect
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor | SpringerLink
FISH analysis using Vysis HER-2/neu SpectrumOrange/CEP17 SpectrumGreen... | Download Scientific Diagram
Alternate Probe Establishing HER2 Status In Double Equivocal Breast Carcinomas - Research Day 2017
Centromere 17 copy number gain reflects chromosomal instability in breast cancer | Scientific Reports
LSI Her-2/neu (Orange)/CEP 17 (Green) -
File:Counting HER2 versus CEP17 probes in FISH of HER2 amplified cell.png - Wikipedia
Fluorescence in situ hybridization of chromosome 17 polysomy in breast cancer using thin tissue sections causes the loss of CEP17 and HER2 signals
LSI Her-2/neu (Orange)/CEP 17 (Green) -
Impact of chromosome 17 centromere copy number increase on patient survival and human epidermal growth factor receptor 2 expression in gastric adenocarcinoma
HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy | PLOS ONE
Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer
HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study | Scientific Reports
Common HER2 (red) and CEP17 (green) status demonstrated using... | Download Scientific Diagram
Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens | PLOS ONE
Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer - Vermij - 2021 - Histopathology - Wiley Online Library
LSI Her-2/neu (Orange)/CEP 17 (Green) -
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells | BMC Cancer
